Zhenbao Island (603567.SH) received the "Approval Notice for Supplementary Drug Application" issued by the State Food and Drug Administration_Individual Stock Information_Market Gold Online

Post date April 5, 2022 — 18:17 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Good news express: The two offices issued the "Opinions on Promoting Urbanization Construction with County Towns as an Important Carrier", the government promoted the vigorous development of green buildings, and Tianbang's sales of commercial pigs in April increased by 34.56% month-on-month

May 9, 2022 — 09:00

Zhenbao Island has entered the golden period of rapid development with the first-mover advantage of the whole industry chain

May 7, 2022 — 11:50

Talents "strengthen the roots" and innovate and "consolidate the foundation", Zhenbao Island moves forward steadily, and the revenue exceeds 4 billion

May 5, 2022 — 14:01

Pharmaceutical business and medicinal materials business soared, and exclusive products released potential Zhenbao Island’s revenue exceeded 4 billion yuan – yqqlm

May 1, 2022 — 11:24

Zhenbaodao Pharmaceutical's revenue will increase by more than 20% in 2021, and Chinese herbal medicine trade will contribute more than half

April 30, 2022 — 20:55

213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement

April 27, 2022 — 15:02

[Investment hedging guide] China Merchants Bank removed Tian Huiyu from the post of director, BBK plans to reduce the repurchased shares, and the performance of Hualian shares was revised down

April 19, 2022 — 07:31

A-share headline listed company (4.19) Stock Financial Industry

April 18, 2022 — 22:42

Zhenbao Island (603567): Indicative Announcement of Heilongjiang Zhenbao Island Pharmaceutical Co., Ltd. on Changes in Shareholders' Equity- CFi.CN Zhongcai.com

April 18, 2022 — 21:42

Home » News » Zhenbao Island (603567.SH) received the "Approval Notice for Supplementary Drug Application" issued by the State Food and Drug Administration_Individual Stock Information_Market Gold Online